Liposomal amphotericin B as a treatment for human leishmaniasis. (Record no. 22279287)

MARC details
000 -LEADER
fixed length control field 01455 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516122254.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201305s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-7623
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1517/14728214.2012.748036
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Balasegaram, Manica
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130501
245 00 - TITLE STATEMENT
Title Liposomal amphotericin B as a treatment for human leishmaniasis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert opinion on emerging drugs
Date of publication, distribution, etc. Dec 2012
300 ## - PHYSICAL DESCRIPTION
Extent 493-510 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amphotericin B
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiprotozoal Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs, Generic
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Health Services Accessibility
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leishmaniasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leishmaniasis, Visceral
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutic Equivalency
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ritmeijer, Koert
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lima, Maria Angeles
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burza, Sakib
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ortiz Genovese, Gemma
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Milani, Barbara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gaspani, Sara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Potet, Julien
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chappuis, François
773 0# - HOST ITEM ENTRY
Title Expert opinion on emerging drugs
Related parts vol. 17
-- no. 4
-- p. 493-510
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1517/14728214.2012.748036">https://doi.org/10.1517/14728214.2012.748036</a>
Public note Available from publisher's website

No items available.